{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:12:27Z","timestamp":1789783947398,"version":"4.0.1"},"reference-count":159,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ymgme.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T06:09:28Z","timestamp":1581487768000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers"],"prefix":"10.1016","volume":"130","author":[{"given":"Eline C.B.","family":"Eskes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sjouke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.I.","family":"Goorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.P.","family":"van Kuilenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.02.002_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.02.002_bb0010","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl. Sci. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","article-title":"The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease","volume":"30","author":"Schuchman","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1073\/pnas.55.2.366","article-title":"The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae","volume":"55","author":"Brady","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0025","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.febslet.2009.11.083","article-title":"Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease","volume":"584","author":"Schuchman","year":"2010","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1042\/BST20130083","article-title":"Metabolic and cellular bases of sphingolipidoses","volume":"41","author":"Sandhoff","year":"2013","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beem.2014.08.004","article-title":"Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening","volume":"29","author":"Kingma","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ejhg.2015.89","article-title":"Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann-Pick disease type B","volume":"24","author":"Acuna","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1086\/503750","article-title":"Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease","volume":"78","author":"Simonaro","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet. J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in the Netherlands and Belgium: disease spectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0065","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.revmed.2016.10.387","article-title":"Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: a retrospective multicentric study of 28 adult cases","volume":"38","author":"Lidove","year":"2017","journal-title":"Rev. Med. Interne."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/gim.2017.7","article-title":"Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency","volume":"19","author":"McGovern","year":"2017","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/humu.22923","article-title":"SMPD1 mutation update: database and comprehensive analysis of published and novel variants","volume":"37","author":"Zampieri","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0085","first-page":"519","volume":"29","author":"Pick","year":"1926","journal-title":"Ergebnisse der Inneren Medizin und Kinderheil-kunde."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0095","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher\u2019s disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/bchm2.1934.229.4-6.151","article-title":"Uber die natur der phosphatide der milz bei Niemann-Pickchen Krankheit","volume":"229","author":"Klenk","year":"1934","journal-title":"Z. Physiol. Chem."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0105","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0021-9258(18)49334-9","article-title":"A reinvestigation of the cerebroside deposited in Gaucher\u2019s disease","volume":"233","author":"Rosenberg","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0110","author":"US National Library of Medicine"},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2014.07.005","article-title":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics","volume":"114","author":"Murray","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/gim.2015.24","article-title":"Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)","volume":"18","author":"McGovern","year":"2016","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2020.02.002_bb0125","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.02.002_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","article-title":"Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency","volume":"116","author":"Wasserstein","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0135","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/PAS.0000000000000659","article-title":"Clearance of hepatic sphingomyelin by Olipudase alfa is associated with improvement in lipid profiles in acid sphingomyelinase deficiency","volume":"40","author":"Thurberg","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0140","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10545-017-0123-6","article-title":"Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months","volume":"41","author":"Wasserstein","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"16","key":"10.1016\/j.ymgme.2020.02.002_bb0145","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1517\/14656560903270520","article-title":"Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships","volume":"10","author":"Hollak","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"issue":"21","key":"10.1016\/j.ymgme.2020.02.002_bb0150","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0160","series-title":"Resource","author":"BEST (Biomarkers, EndpointS, and other Tools)","year":"2016"},{"key":"10.1016\/j.ymgme.2020.02.002_bb0165","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","article-title":"Biomarkers in lysosomal storage diseases","author":"Cox","year":"2006"},{"key":"10.1016\/j.ymgme.2020.02.002_bb0170","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.ymgme.2020.02.002_bb0175","author":"Food and Drug Administration (FDA)"},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0180","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1373\/clinchem.2016.254649","article-title":"Waste, leaks, and failures in the biomarker pipeline","volume":"63","author":"Ioannidis","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cca.2016.06.037","article-title":"Biomarker development targeting unmet clinical needs","volume":"460","author":"Monaghan","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0195","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"9615","key":"10.1016\/j.ymgme.2020.02.002_bb0200","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0205","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.2008.05640.x","article-title":"Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C","volume":"24","author":"Yatsuji","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0215","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2559.2006.02355.x","article-title":"Pulmonary involvement by Niemann-Pick disease. A report of six cases","volume":"48","author":"Nicholson","year":"2006","journal-title":"Histopathology."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/s1806-37562017000000062","article-title":"Niemann-Pick disease type B: HRCT assessment of pulmonary involvement","volume":"43","author":"Freitas","year":"2017","journal-title":"J. Bras. Pneumol."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0225","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2016.0518","article-title":"Association between interstitial lung abnormalities and all-cause mortality","volume":"315","author":"Putman","year":"2016","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0230","article-title":"Prognosis and follow-up of idiopathic pulmonary fibrosis","volume":"6","author":"Fernandez Fabrellas","year":"2018","journal-title":"Med. Sci. (Basel)"},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0235","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00595-007-3641-2","article-title":"Niemann-Pick disease resulting in spontaneous splenic rupture in an adult: report of a case","volume":"38","author":"Chen","year":"2008","journal-title":"Surg. Today"},{"issue":"12","key":"10.1016\/j.ymgme.2020.02.002_bb0240","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0046-8177(82)80249-9","article-title":"Adult Niemann-Pick disease with sea-blue histiocytes in the spleen","volume":"13","author":"Dawson","year":"1982","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.revmed.2014.10.367","article-title":"Acid sphingomyelinase deficiency and spleen trauma: splenectomy or not splenectomy?","volume":"36","author":"Lidove","year":"2015","journal-title":"Rev. Med. Interne."},{"issue":"4","key":"10.1016\/j.ymgme.2020.02.002_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0248-8663(05)82868-1","article-title":"Type B Niemann-Pick disease and sea-blue histiocytes syndrome","volume":"12","author":"Rodon","year":"1991","journal-title":"Rev. Med. Interne."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208286","article-title":"Niemann-Pick type B in adulthood","volume":"2015","author":"Simoes","year":"2015","journal-title":"BMJ Case Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jus.2009.06.001","article-title":"Contrast-enhanced ultrasonography in nodular splenomegaly associated with type B Niemann-Pick disease: an atypical hemangioma enhancement pattern","volume":"12","author":"Benedetti","year":"2009","journal-title":"J. Ultrasound."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0265","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-014-0112-x","article-title":"Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications","volume":"9","author":"van Dussen","year":"2014","journal-title":"Orphanet. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9610(91)90363-I","article-title":"A 27-year experience with splenectomy for Gaucher\u2019s disease","volume":"161","author":"Fleshner","year":"1991","journal-title":"Am. J. Surg."},{"issue":"8","key":"10.1016\/j.ymgme.2020.02.002_bb0275","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0280","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10545-006-0226-y","article-title":"Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries","volume":"29","author":"Ishii","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2020.02.002_bb0290","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/thx.38.11.873","article-title":"Cor pulmonale in an adult secondary to Niemann-Pick disease","volume":"38","author":"Lever","year":"1983","journal-title":"Thorax."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0295","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","article-title":"Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B","volume":"36","author":"Wasserstein","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0046-8177(97)90141-6","article-title":"Heterogeneity of liver disorder in type B Niemann-Pick disease","volume":"28","author":"Takahashi","year":"1997","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bcmd.2016.12.010","article-title":"Are transient and shear wave elastography useful tools in Gaucher disease?","volume":"68","author":"Webb","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"22","key":"10.1016\/j.ymgme.2020.02.002_bb0315","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0325","first-page":"117","article-title":"Cirrhosis and liver failure: expanding phenotype of acid sphingomyelinase-deficient niemann-pick disease in adulthood","volume":"15","author":"Lidove","year":"2015","journal-title":"JIMD Rep."},{"issue":"12","key":"10.1016\/j.ymgme.2020.02.002_bb0330","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ppul.20725","article-title":"Lung disease in Niemann-Pick disease","volume":"42","author":"Guillemot","year":"2007","journal-title":"Pediatr. Pulmonol."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0335","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.rmed.2012.06.014","article-title":"Different features of lung involvement in Niemann-Pick disease and Gaucher disease","volume":"106","author":"Gulhan","year":"2012","journal-title":"Respir. Med."},{"issue":"145","key":"10.1016\/j.ymgme.2020.02.002_bb0340","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0009-2017","article-title":"The role of macrophages in interstitial lung diseases: Number 3 in the Series \u201cPathology for the clinician\u201d Edited by Peter Dorfmuller and Alberto Cavazza","volume":"26","author":"Rossi","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0345","first-page":"861","article-title":"Niemann-Pick disease type B identified following an episode of bronchopneumonia","volume":"25","author":"Herve","year":"2008","journal-title":"Rev. Mal. Respir."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0350","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiol.2381041696","article-title":"Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing","volume":"238","author":"Mendelson","year":"2006","journal-title":"Radiology."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020327","article-title":"Molecular pathways and respiratory involvement in lysosomal storage diseases","volume":"20","author":"Faverio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0360","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1148\/rg.352140197","article-title":"Histiocytic disorders of the chest: imaging findings","volume":"35","author":"Ahuja","year":"2015","journal-title":"Radiographics."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejrad.2004.07.003","article-title":"Metabolic lung disease: imaging and histopathologic findings","volume":"54","author":"Chung","year":"2005","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.ymgme.2020.02.002_bb0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00408-016-9893-0","article-title":"Pulmonary involvement in Niemann-Pick disease: a state-of-the-art review","volume":"194","author":"von Ranke","year":"2016","journal-title":"Lung."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0375","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2007-3016","article-title":"A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B","volume":"122","author":"McGovern","year":"2008","journal-title":"Pediatrics."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-019-1029-1","article-title":"Chronic visceral acid sphingomyelinase deficiency (Niemann-Pick disease type B) in 16 polish patients: long-term follow-up","volume":"14","author":"Lipinski","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0385","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1515\/cclm-2019-0380","article-title":"The role of platelets in bleeding in patients with thrombocytopenia and hematological disease","volume":"57","author":"Vinholt","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0390","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","article-title":"Lipid abnormalities in children with types A and B Niemann Pick disease","volume":"145","author":"McGovern","year":"2004","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0395","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2020.02.002_bb0400","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006636","volume":"6","author":"van Capelleveen","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.atherosclerosis.2008.08.027","article-title":"Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease","volume":"204","author":"de Fost","year":"2009","journal-title":"Atherosclerosis."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0410","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/bcmd.2001.0474","article-title":"Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease","volume":"27","author":"Hollak","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0415","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiology.182.2.1732964","article-title":"Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease","volume":"182","author":"Johnson","year":"1992","journal-title":"Radiology."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0420","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10545-014-9726-3","article-title":"Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned","volume":"37","author":"van Dussen","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0425","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2013.11.012","article-title":"Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients","volume":"111","author":"Chuang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ab.2017.02.019","article-title":"Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick a\/B and C diseases","volume":"525","author":"Kuchar","year":"2017","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0435","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0440","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cca.2018.08.039","article-title":"The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency","volume":"486","author":"Deodato","year":"2018","journal-title":"Clin. Chim. Acta."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181700","article-title":"LC-MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease","volume":"12","author":"Pettazzoni","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0450","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2017.12.431","article-title":"Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature","volume":"123","author":"Voorink-Moret","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0455","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","article-title":"Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study","volume":"57","author":"Polo","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0460","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0465","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.RA119000157","article-title":"N-acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease","volume":"60","author":"Sidhu","year":"2019","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.ymgme.2020.02.002_bb0470","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.ymgme.2020.02.002_bb0475","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0480","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.ymgme.2020.02.002_bb0485","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ymgme.2018.10.007","article-title":"Dissociation of globotriaosylceramide and impaired endothelial function in alpha-galactosidase-A deficient EA.hy926 cells","volume":"125","author":"Kaissarian","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"20","key":"10.1016\/j.ymgme.2020.02.002_bb0490","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/hmg\/ddv291","article-title":"Lyso-Gb3 activates Notch1 in human podocytes","volume":"24","author":"Sanchez-Nino","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.002_bb0495","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/ndt\/gfq306","article-title":"Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy","volume":"26","author":"Sanchez-Nino","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0500","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0505","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2015.01.084","article-title":"The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain","volume":"594","author":"Choi","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"13","key":"10.1016\/j.ymgme.2020.02.002_bb0510","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7643","key":"10.1016\/j.ymgme.2020.02.002_bb0515","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0520","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.smim.2018.02.006","article-title":"An unexpected player in Gaucher disease: the multiple roles of complement in disease development","volume":"37","author":"Pandey","year":"2018","journal-title":"Semin. Immunol."},{"issue":"40","key":"10.1016\/j.ymgme.2020.02.002_bb0525","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","article-title":"Glucosylsphingosine promotes alpha-Synuclein pathology in mutant GBA-associated Parkinson\u2019s disease","volume":"37","author":"Taguchi","year":"2017","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.ymgme.2020.02.002_bb0530","article-title":"Serum profiling; the analysis of therapeutic proteins and diagnostic markers for lysosomal storage disorders by LC-MS","volume":"4","author":"Vissers","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymgme.2020.02.002_bb0535","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","article-title":"Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"61","author":"Gomez-Munoz","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"42","key":"10.1016\/j.ymgme.2020.02.002_bb0540","doi-asserted-by":"crossref","first-page":"40911","DOI":"10.1074\/jbc.M301804200","article-title":"Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase","volume":"278","author":"Aguilera","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0545","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ymgme.2020.02.002_bb0550","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/epr.09.54","article-title":"Gaucher disease: a model disorder for biomarker discovery","volume":"6","author":"Boot","year":"2009","journal-title":"Expert Rev. Proteomics."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0555","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12098-009-0249-0","article-title":"Plasma chitotriosidase activity in children with lysosomal storage disorders","volume":"77","author":"Sheth","year":"2010","journal-title":"Indian J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0560","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10545-006-0363-3","article-title":"Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A\/B and C","volume":"29","author":"Ries","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0565","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10545-005-4416-9","article-title":"Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease","volume":"28","author":"Brinkman","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0570","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2016.03.004","article-title":"Clinical evaluation of chitotriosidase enzyme activity in Gaucher and Niemann Pick A\/B diseases: a retrospective study from India","volume":"457","author":"Kadali","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.ymgme.2020.02.002_bb0575","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2004.06.008","article-title":"Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases","volume":"37","author":"Wajner","year":"2004","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0580","doi-asserted-by":"crossref","first-page":"69","DOI":"10.15407\/ubj88.01.069","article-title":"Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases","volume":"88","author":"Olkhovych","year":"2016","journal-title":"Ukr. Biochem. J."},{"issue":"40","key":"10.1016\/j.ymgme.2020.02.002_bb0585","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0590","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MCP.0b013e328356d03c","article-title":"Biomarkers in idiopathic pulmonary fibrosis","volume":"18","author":"Zhang","year":"2012","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0595","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0600","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcmd.2009.09.005","article-title":"CCL18 as an alternative marker in Gaucher and Niemann-Pick disease with chitotriosidase deficiency","volume":"44","author":"Chang","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010066","article-title":"Glycoprotein non-metastatic protein B: an emerging biomarker for lysosomal dysfunction in macrophages","volume":"20","author":"van der Lienden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0610","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/2211-5463.12078","article-title":"Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models","volume":"6","author":"Kramer","year":"2016","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0615","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","article-title":"Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease","volume":"68","author":"Murugesan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147208","article-title":"Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease","volume":"11","author":"Marques","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0625","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4049\/jimmunol.159.3.1140","article-title":"A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha\/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes","volume":"159","author":"Hieshima","year":"1997","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0630","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10545-009-1064-5","article-title":"Different dose-dependent correction of MIP-1beta and chitotriosidase during initial enzyme replacement therapy","volume":"32","author":"van Breemen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0635","first-page":"153","article-title":"Long-term response in biochemical markers of bone turnover during enzyme replacement therapy in a case-series of patients with Gaucher disease type I from northern Greece","volume":"20","author":"Vargiami","year":"2016","journal-title":"Hippokratia."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0640","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"van Breemen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0645","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ymthe.2005.08.020","article-title":"Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice","volume":"13","author":"Dhami","year":"2006","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0650","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1194\/jlr.D044024","article-title":"Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease","volume":"55","author":"Lin","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0655","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2016.02.030","article-title":"Determination of serum cholestane-3beta,5alpha,6beta-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease","volume":"169","author":"Kannenberg","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.ymgme.2020.02.002_bb0660","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1194\/jlr.M060343","article-title":"de las Heras J, et al. Cholestane-3beta,5alpha,6beta-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency","volume":"56","author":"Pajares","year":"2015","journal-title":"J. Lipid Res."},{"issue":"56","key":"10.1016\/j.ymgme.2020.02.002_bb0665","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001417","article-title":"Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease","volume":"2","author":"Porter","year":"2010","journal-title":"Sci Transl Med."},{"issue":"4","key":"10.1016\/j.ymgme.2020.02.002_bb0670","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","article-title":"Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review","volume":"118","author":"Vanier","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0675","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2015.12.018","article-title":"Rapid diagnosis of 83 patients with Niemann Pick type C disease and related cholesterol transport disorders by Cholestantriol screening","volume":"4","author":"Reunert","year":"2016","journal-title":"EBioMedicine."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.002_bb0680","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M061978","article-title":"Evaluation of plasma cholestane-3beta,5alpha,6beta-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism","volume":"57","author":"Boenzi","year":"2016","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0685","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clinbiochem.2015.03.007","article-title":"LC-MS\/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases","volume":"48","author":"Klinke","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0690","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cca.2014.07.010","article-title":"A new simple and rapid LC-ESI-MS\/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease","volume":"437","author":"Boenzi","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2020.02.002_bb0695","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2016.01.003","article-title":"Comprehensive evaluation of plasma 7-Ketocholesterol and Cholestan-3beta,5alpha,6beta-Triol in an Italian cohort of patients affected by Niemann-Pick disease due to NPC1 and SMPD1 mutations","volume":"455","author":"Romanello","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2020.02.002_bb0700","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2015.11.015","article-title":"Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry","volume":"1439","author":"Pataj","year":"2016","journal-title":"J. Chromatogr. A"},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.002_bb0705","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ymgme.2014.07.004","article-title":"Health economic evaluation of plasma oxysterol screening in the diagnosis of Niemann-Pick type C disease among intellectually disabled using discrete event simulation","volume":"114","author":"van Karnebeek","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0710","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijdevneu.2017.11.007","article-title":"Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients","volume":"66","author":"Hammerschmidt","year":"2018","journal-title":"Int. J. Dev. Neurosci."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0715","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1194\/jlr.D015735","article-title":"A sensitive and specific LC-MS\/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma","volume":"52","author":"Jiang","year":"2011","journal-title":"J. Lipid Res."},{"issue":"337","key":"10.1016\/j.ymgme.2020.02.002_bb0720","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2326","article-title":"Development of a bile acid-based newborn screen for Niemann-Pick disease type C","volume":"8","author":"Jiang","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"4 Pt 1","key":"10.1016\/j.ymgme.2020.02.002_bb0725","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/jhep.2002.35617","article-title":"Relevance of Niemann-Pick type C1 protein expression in controlling plasma cholesterol and biliary lipid secretion in mice","volume":"36","author":"Amigo","year":"2002","journal-title":"Hepatology."},{"issue":"11","key":"10.1016\/j.ymgme.2020.02.002_bb0730","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/1873-3468.12196","article-title":"Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease","volume":"590","author":"Mazzacuva","year":"2016","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0735","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"issue":"Pt 5","key":"10.1016\/j.ymgme.2020.02.002_bb0740","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0004563214568871","article-title":"Focused metabolomics using liquid chromatography\/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3beta-hydroxysteroid dehydrogenase deficiency","volume":"52","author":"Maekawa","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0745","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cca.2019.03.1610","article-title":"Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann-Pick disease type C","volume":"494","author":"Maekawa","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.ymgme.2020.02.002_bb0750","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.steroids.2013.05.017","article-title":"LC\/ESI-MS\/MS analysis of urinary 3beta-sulfooxy-7beta-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann-Pick type C disease","volume":"78","author":"Maekawa","year":"2013","journal-title":"Steroids."},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.002_bb0755","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.201012-2079ED","article-title":"Strengths and limitations of the six-minute-walk test: a model biomarker study in idiopathic pulmonary fibrosis","volume":"183","author":"Heresi","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0760","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200604-488OC","article-title":"Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test","volume":"174","author":"Flaherty","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0765","first-page":"119","article-title":"Burden of illness in acid sphingomyelinase deficiency: a retrospective chart review of 100 patients","volume":"41","author":"Cox","year":"2018","journal-title":"JIMD Rep."},{"issue":"11","key":"10.1016\/j.ymgme.2020.02.002_bb0770","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/ajmg.a.33077","article-title":"Psychosocial aspects of patients with Niemann-Pick disease, type B","volume":"149A","author":"Henderson","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0775","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1572-0241.2001.03956.x","article-title":"Health-related quality of life in chronic liver disease: the impact of type and severity of disease","volume":"96","author":"Younossi","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.002_bb0780","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.21193","article-title":"Factors associated with poor health-related quality of life of patients with cirrhosis","volume":"120","author":"Marchesini","year":"2001","journal-title":"Gastroenterology."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.002_bb0785","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/thx.2004.035220","article-title":"Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review","volume":"60","author":"Swigris","year":"2005","journal-title":"Thorax."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.002_bb0790","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mcp.0000239553.93443.d8","article-title":"Quality of life and health status in interstitial lung diseases","volume":"12","author":"De Vries","year":"2006","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.ymgme.2020.02.002_bb0795","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-1-20","article-title":"The Stanford health assessment questionnaire: dimensions and practical applications","volume":"1","author":"Bruce","year":"2003","journal-title":"Health Qual. Life Outcomes"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220300524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220300524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:24:41Z","timestamp":1761089081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220300524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1096719220300524"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.02.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}